Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Top Stories > FTSE 100 climbs on pharma boost, UK CPI in focus
    Top Stories

    FTSE 100 climbs on pharma boost, UK CPI in focus

    Published by Jessica Weisman-Pitts

    Posted on October 17, 2023

    2 min read

    Last updated: January 31, 2026

    An image of the London Stock Exchange, symbolizing the FTSE 100's rise following positive pharmaceutical news. This reflects investor optimism ahead of upcoming UK CPI data.
    FTSE 100 index rises as UK inflation data looms - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:UK economyfinancial marketsinvestment

    FTSE 100 climbs on pharma boost, UK CPI in focus

    By Khushi Singh and Bansari Mayur Kamdar

    (Reuters) -Britain’s FTSE 100 rose on Tuesday after latest figures showing a weakening labour market lifted investor sentiment ahead of highly awaited inflation data later this week.

    The blue-chip FTSE 100 gained 0.6%, while the mid-cap index closed 1.0% higher.

    AstraZeneca was up 2.7% as Guggenheim raised its price target on the heavyweight drugmaker, while the broader healthcare index added 2.1%.

    Rolls-Royce rose 1.0% after the engineering company said it would cut 2,000-2,500 roles across its global business as part of a cost-reduction drive.

    Data showed growth in British workers’ regular pay – which is being watched closely by the Bank of England – slowed from a previous record high, with job vacancies also declining.

    The rate-sensitive homebuilders’ index added 2.3% and led sectoral gains, while Bellway reversed early losses and gained 3.3% even as the homebuilder forecast about a one-third slump in annual output.

    “UK earnings data suggests that signs of slack continue to emerge, highlighting the fragility of the economy as elevated inflation and the Bank of England’s (BoE) rate hikes take their toll on the jobs market,” said Victoria Scholar, head of investment at Interactive Investor.

    Recent labour market data have shown a softening economy which is likely to lead to slower wage growth and reduced inflation pressure, said BoE policymaker Swati Dhingra, who has consistently voted against rate rises this year.

    The focus turned to UK CPI data due on Wednesday for further cues on BoE’s rate hike path.

    Energy stocks rose 0.9% as oil prices moved higher ahead of a trip by U.S. President Joe Biden to the Middle East. [O/R]

    St. James’s Place slipped 0.5% after it said it will change its fee structure for most new investment bonds and pensions.

    Meanwhile, Jupiter Fund Management fell 9.8% after reporting bigger than expected net outflows in its third quarter as it grapples with muted retail investor appetite and volatile markets amid high inflation.

    (Reporting by Khushi Singh and Bansari Mayur Kamdar in Bengaluru; editing by Varun H K and Mark Heinrich)

    Frequently Asked Questions about FTSE 100 climbs on pharma boost, UK CPI in focus

    1What is inflation?

    Inflation is the rate at which the general level of prices for goods and services rises, eroding purchasing power. Central banks attempt to limit inflation to keep the economy running smoothly.

    2What is the FTSE 100?

    The FTSE 100 is a stock market index that represents the 100 largest companies listed on the London Stock Exchange, based on market capitalization. It is a key indicator of the UK stock market's performance.

    3What is the Consumer Price Index (CPI)?

    The Consumer Price Index (CPI) measures the average change over time in the prices paid by consumers for a basket of goods and services. It is a key indicator of inflation.

    4What is a blue-chip stock?

    A blue-chip stock refers to shares of a well-established company with a history of stable earnings, reliable growth, and a reputation for quality. These stocks are considered safe investments.

    More from Top Stories

    Explore more articles in the Top Stories category

    Image for Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Image for Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Image for Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Image for Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Image for Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Image for Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Image for Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Image for PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    Image for A Notable Update for Employee Health Benefits:
    A Notable Update for Employee Health Benefits:
    Image for Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Image for Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Image for ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    View All Top Stories Posts
    Previous Top Stories PostAutomakers blast US plan to hike fuel efficiency rules
    Next Top Stories PostExclusive-Brookfield weighs move into UK pension insurance market -sources